LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

LLY

905.59

-1.35%↓

UNH

570.56

+0.14%↑

NVO

117.32

-0.78%↓

JNJ

162.66

-1.43%↓

ABBV

186.25

-1.36%↓

Kodu・Aktsiate loetelu・Bio-Rad Laboratories Inc

Bio-Rad Laboratories Inc

Avatud

Sektor Tervishoid

340.65 -1.66

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

340.41

Max

346.39

Põhinäitajad
By Trading Economics
Sissetulek	-2.5B -2.2B
Müük	28M 639M
Aktsiakasum	3.11
Kasumimarginaal	-339.153
Töötajad	8,030
EBITDA	-3.3B -2.7B

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+8.07 upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	30. okt 2024

Turustatistika
By TradingEconomics
Turukapital	-225M 9.5B
Eelmine avamishind	342.31
Eelmine sulgemishind	340.65

Uudiste sentiment

By Acuity

50%

144 / 366 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

339.22 / 350.53 Toetus ja vastupanu

Bio-Rad Laboratories Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

18. okt 2024, 22:42 UTC

Kuumad aktsiad

Stocks to Watch: Spirit Airlines, Cigna Group, Humana

18. okt 2024, 22:33 UTC

Suurimad hinnamuutused turgudel

Cinga, Humana Shares Move in Opposite Directions on Report of Merger Talks

18. okt 2024, 21:16 UTC

Omandamised, ülevõtmised, äriostud

Cigna, Humana Enter Merger Discussions Again, Bloomberg Reports

20. okt 2024, 22:45 UTC

Peamised uudised

Stocks Poised for Higher Open -- Barrons.com

20. okt 2024, 18:00 UTC

Peamised uudised

Tesla, General Motors, AT&T, Western Digital, and More Stocks to Watch This Week -- Barrons.com

20. okt 2024, 13:00 UTC

Peamised uudised

Cargo On-Time Rates Are Dismal. Two Shipowners Have a Plan to Fix That. -- WSJ

20. okt 2024, 09:30 UTC

Peamised uudised

Boeing's CEO Is Shrinking the Jet Maker to Stop Its Crisis From Spiraling -- WSJ

19. okt 2024, 17:47 UTC

Peamised uudised

Boeing, Union Reach Wage Deal to End Strike -- 3rd Update

19. okt 2024, 15:33 UTC

Peamised uudised

Boeing, Union Reach Wage Deal to End Strike -- 2nd Update

19. okt 2024, 15:10 UTC

Peamised uudised

Omandamised, ülevõtmised, äriostud

Berkshire Buys Another Chunk of Sirius XM Stock. Its Stake Hits 32%. -- Barrons.com

19. okt 2024, 14:51 UTC

Peamised uudised

Boeing, Union Reach Wage Deal to End Strike -- Update

19. okt 2024, 14:43 UTC

Peamised uudised

Boeing, Union Reach Wage Deal to End Strike -- WSJ

19. okt 2024, 11:00 UTC

Peamised uudised

Tulu

Why Do Health Insurers Keep Getting Slammed With Higher Costs? -- Heard on the Street -- WSJ

19. okt 2024, 08:30 UTC

Peamised uudised

Interest Rate Uncertainty Is At a Financial-Crisis Era High. Here's How We Know. -- Barrons.com

19. okt 2024, 08:20 UTC

Market Talk

Tulu

Tech, Media & Telecom Roundup: Market Talk

19. okt 2024, 07:30 UTC

Peamised uudised

Bitcoin or Gold? Why Not Own Both? -- Barrons.com

18. okt 2024, 23:44 UTC

Peamised uudised

American Airlines Jet Involved in Close Call Over Austin Airport -- WSJ

18. okt 2024, 21:31 UTC

Peamised uudised

Tulu

CVS Shares Fall After Earnings Warning, CEO Ouster -- 3rd Update

18. okt 2024, 20:59 UTC

Omandamised, ülevõtmised, äriostud

An Elevance Health Exec Canceled His Plan to Sell Stock Weeks Before the Plunge -- Barrons.com

18. okt 2024, 20:50 UTC

Market Talk

Tulu

Tech, Media & Telecom Roundup: Market Talk

18. okt 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

18. okt 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

18. okt 2024, 20:09 UTC

Peamised uudised

Netflix Stock Jumps on Earnings; Amex Weighs on Dow -- WSJ

18. okt 2024, 19:14 UTC

Market Talk

Oil Futures Post Sharp Weekly Losses -- Market Talk

18. okt 2024, 19:06 UTC

Market Talk

U.S. Natural Gas Falls on Mild Weather Outlook -- Market Talk

18. okt 2024, 18:03 UTC

Peamised uudised

Netflix Stock Jumps on Earnings; Amex Weighs on Dow -- WSJ

18. okt 2024, 17:31 UTC

Market Talk

Starbucks Taps Former Chipotle Executive for Brand Role -- Market Talk

18. okt 2024, 17:24 UTC

Market Talk

U.S. Oil Rig Count Rises by 1 to 482 -- Market Talk

18. okt 2024, 17:12 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Intel to Sell Minority Stake in Altera for $17 Billion, Report Says. It's Part of a Bigger Turnaround Plan. -- Barrons.com

18. okt 2024, 16:57 UTC

Tulu

Costco Wholesale Stock Has Been on a Roll. How the Retailer Can Keep Growing. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Bio-Rad Laboratories Inc Prognoos

Hinnasiht

By TipRanks

8.07% tõus

12 kuu keskmine prognoos

Keskmine 374.33 USD 8.07%

Kõrge 401 USD

Madal 315 USD

Põhineb 6 Wall Streeti analüütiku instrumendi Bio-Rad Laboratories Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

6 ratings

Osta

Hoia

Müü

Põhineb 6 analüütiku instrumendi Bio-Rad Laboratories Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

339.22 / 350.53Toetus ja vastupanu

Recent bullish events outweigh bearish events.

All events are bullish.

Bullish events outweigh bearish events.

Sentiment

By Acuity

144 / 366 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.